Immunohistochemistry (IHC) is a useful predictive biomarker to detect PD-L1 expression, but obtaining adequate tumor tissue for PD-L1 staining is not available in some patients and tumor tissue varies regarding time and space. Here, CD274 is linked to neoplasm.